KYG3887G1091
KYG3887G1091
GIANT BIOGENE
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.518.512.000 | 5.538.812.000 | 0.4% |
| Cost of Revenue | 1.085.162.000 | 991.897.000 | 9.4% |
| Gross Profit | 4.433.350.000 | 4.546.915.000 | 2.5% |
| 2.292.857.000 | 2.238.283.000 | 2.4% | |
| Operating Income | 2.140.493.000 | 2.308.632.000 | 7.3% |
| Pretax Income | 2.350.304.000 | 2.457.754.000 | 4.4% |
| Net Income Common Stockholders | 1.914.836.000 | 2.062.347.000 | 7.2% |
| -- | -- | -- | |
| -- | -- | -- |